Scoliosis NT Harmony

Common Questions About Supplements

How long do you recommend taking the listed supplements?

Our chief concern at ScoliSMART is how these products may affect the outcomes of your child’s scoliosis during growth. However, once your child reaches skeletal maturity, or for Adult patients, your provider may recommend these products on an ongoing basis to address any non-spinal symptoms or genetic variants.

Will these products have any negative side effects?

The supplements we recommend are all-natural, organic, Kosher, and non-GMO. However, parents should discuss these supplements with their pediatrician if they are taking any prescription medications.

What can be expected once supplementation starts?

Although the primary goal of these supplements is to support scoliosis therapy, many parents notice positive improvements in their children’s behavior and focus as well.

Will my insurance cover the cost of the supplements?

Although health insurances do not typically cover supplements, many FSA or HSA accounts will reimburse you for them if your treating provider writes a letter of medical necessity.

Will taking the recommended supplements alone improve scoliosis?

No. The nutritional interventions may help prevent further curve progression, as well as improve treatment outcomes. The recommendations in this report are intended to be done in conjunction with a scoliosis-specific exercise program like ScoliSMART BootCamp or the Scoliosis Activity Suit.

What if taking pills is a problem?

Many of the supplements are available in liquid and chewable forms. Also, capsules can be opened and the powdered contents can be mixed in juices or applesauce.

Related Research

1. Holliday J, Cleaver M. Medicinal value of the caterpillar fungi species of the genus Cordyceps (Fr.) Link (Ascomycetes). A review. International Journal of Medicinal Mushrooms. 2008;10(3):219-34.

2. Chan SW. Panax ginseng Rhodiola rosea and Schisandra chinensis. Int J Food Sci Nutr. 2012 Mar;63 Suppl 1:75-81.

3. Morningstar M. Neurotransmitter status and idiopathic scoliosis: A commentary on pathways, testing, clinical utility, and treatment. Curr Pediatr Res 2016; 20 (1&2): 14-19